Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

International Myeloma Foundation’s Journalist Workshop features multiple myeloma related highlights from ASH

Home/Research, Supplements/Drugs/International Myeloma Foundation’s Journalist Workshop features multiple myeloma related highlights from ASH

International Myeloma Foundation’s Journalist Workshop features multiple myeloma related highlights from ASH

I just finished writing an article about Monday’s night International Myeloma Foundation’s Journalist Workshop.  I will provide a link to the article as soon as it runs on the IMF’s website.

Here’s an excerpt/preview from the article as I set the scene from the 90 minute media event:

Monday evening I attended the IMF’s post-ASH Journalist workshop at the Sheraton San Diego Hotel.

The event was an interesting mix of medical science and inspiration.

Dr. Brian Durie, Chairman and co-founder of the IMF, moderated the event.
60 journalists and physicians from more than a dozen countries followed along with the aid of translators in four different languages, including Russian, which I found interesting.

There were also a number of multiple myeloma patients in attendance, including the now famous marathon running patient –nicknamed Minnesota Don–Don Wright and his family.

I sat between a freelance medical writer from England and a researcher who works with transplant patients from Portugal.  

Along with Dr. Durie, Dr. Robert Orlowski with M.D. Anderson Cancer Center in Houston, Dr. Paul Richardson from Dana-Farber in Boston and Professor Phillippe Moreau from France joined Dr. Durie on the stage.

The primary focus of the event was sort of “the best of ASH” from a multiple myeloma research perspective.

The rest of the article provides a brief outline of the research data presented by the panel of myeloma experts seated at a pair of banquet tables located in the front of the room.

I also spend a lot of time writing about Don Wright’s amazing emergence as one of the hopeful faces of multiple myeloma.

Keeping this in mind, I don’t want to repeat myself here.  Instead, I would like to share my detailed notes with you, and go into a bit more detail about results from the studies–presented this weekend at ASH–that each doctor felt were most important.

I will start that tomorrow.  Feel good and keep smiling!  Pat